Status:

ACTIVE_NOT_RECRUITING

Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.

Lead Sponsor:

Lovoria Williams

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study seeks to establish the efficacy of identifying weight loss nonresponders early in a Diabetes Prevention Program (DPP) intervention in 20 community settings (primarily churches and community...

Eligibility Criteria

Inclusion

  • self-described as Black
  • non-diabetic
  • body mass index (BMI) equal to or greater than 25
  • CDC diabetes risk assessment greater than or equal to 5 or diabetes pre-diagnosis or history of gestational diabetes
  • live within driving distance of participating church/site

Exclusion

  • diagnosed Type 1 or 2 diabetes
  • pregnant or planning to become pregnant during study period
  • contraindications to moderate physical activity
  • serious medical condition that contradicts weight loss
  • not Black or African American

Key Trial Info

Start Date :

February 18 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2026

Estimated Enrollment :

403 Patients enrolled

Trial Details

Trial ID

NCT04757519

Start Date

February 18 2021

End Date

June 30 2026

Last Update

February 7 2025

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

First Corinthian Baptist Church

Frankfort, Kentucky, United States, 40601

2

Heavenly Outpour

Frankfort, Kentucky, United States, 40601

3

Consolidated Baptist Church

Lexington, Kentucky, United States, 40505

4

Historic St. Paul AME Church

Lexington, Kentucky, United States, 40507

Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention. | DecenTrialz